You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Harvard Business School
Medtronic
AstraZeneca
Mallinckrodt

Last Updated: September 30, 2020

DrugPatentWatch Database Preview

Abametapir - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for abametapir and what is the scope of freedom to operate?

Abametapir is the generic ingredient in one branded drug marketed by Dr Reddys Labs Sa and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Abametapir has thirty-four patent family members in fifteen countries.

Summary for abametapir
International Patents:34
US Patents:5
Tradenames:1
Applicants:1
NDAs:1
Bulk Api Vendors: 86
Clinical Trials: 5
Patent Applications: 335
DailyMed Link:abametapir at DailyMed
Recent Clinical Trials for abametapir

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Hatchtech Pty LtdPhase 2
Hatchtech Pty LtdPhase 3
AccelovancePhase 3

See all abametapir clinical trials

US Patents and Regulatory Information for abametapir

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Sa XEGLYZE abametapir LOTION;TOPICAL 206966-001 Jul 24, 2020 RX Yes Yes   Start Trial   Start Trial Y Y   Start Trial
Dr Reddys Labs Sa XEGLYZE abametapir LOTION;TOPICAL 206966-001 Jul 24, 2020 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Dr Reddys Labs Sa XEGLYZE abametapir LOTION;TOPICAL 206966-001 Jul 24, 2020 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Dr Reddys Labs Sa XEGLYZE abametapir LOTION;TOPICAL 206966-001 Jul 24, 2020 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Dr Reddys Labs Sa XEGLYZE abametapir LOTION;TOPICAL 206966-001 Jul 24, 2020 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
McKinsey
Mallinckrodt
Merck
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.